Recovery of rats with fulminant hepatic failure by using a hybrid artificial liver support system with polyurethane foam/rat hepatocyte spheroids

International Journal of Artificial Organs

Volumn 25, Issue 12, 2002, Pages 1144-1152

  Sakiyama, R ^a   Nakazawa, K ^b   Ijima, H ^a   Mizumoto, H ^a   Kajiwara, T ^a   Ito, M ^c   Ishibashi, H ^c   Funatsu, Kazumori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF KITAKYUSHU   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

Fulminant hepatic failure; Hybrid artificial liver support system; Liver regeneration; Polyurethane foam; Rat; Recovery; Spheroids

Indexed keywords

ARTIFICIAL ORGANS; BLOOD; POLYURETHANES; RECOVERY; RIGID FOAMED PLASTICS;

10 MINUTES; ARTIFICIAL LIVER SUPPORT SYSTEMS; FULMINANT HEPATIC FAILURES; HEPATOCYTE/SPHEROID; HEPATOCYTES; HYBRID ARTIFICIAL LIVER SUPPORT SYSTEM; LIVER REGENERATION; POLYURETHANE FOAM; RAT HEPATOCYTES; SPHEROID;

RATS;

ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUCOSE; LACTATE DEHYDROGENASE; POLYURETHAN FOAM;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL LIVER; BLOOD COMPONENT; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; FATALITY; FOAM; GLUCOSE BLOOD LEVEL; HYBRID; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER ISCHEMIA; LIVER REGENERATION; LIVER RESECTION; MALE; MITOSIS; NONHUMAN; RAT; SPHEROID CELL;

EID: 0346890192     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501205     Document Type: Article

References (31)

1. Sussman NL, Chong MG, Koussayer T, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist. Hepatology 1992; 16: 60-5.
2. Rozga J, Williams F, Ro M, et al. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17: 253-65.
3. Nyberg SL, Shirabe K, Peshwa MV, et al. Extracorporeal application of a gel-entrapment, bioartificial liver: Demonstration of drug metabolism and other biochemical function. Cell Transplant 1993; 2: 441.
4. Gerlach JC, Encke J, Hole O, Muller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 1994; 58: 984-8.
5. Patzer II JF, Mazariegos GV, Lopez R, et al. Novel bioartificial liver support system: Preclinical evaluation. Ann N Y Acad Sci 1999; 875: 340-52.
6. Naruse K, Sakai Y, Nagashima I, Jiang GX, Suzuki M, Muto T. Comparison of porcine hepatocyte spheroids and single hepatocytes in the non-woven fabric bioartificial liver module. Int J Artif Organs 1996; 19: 605-9.
7. Flendrig LM, Velde AA, Chamuleau RAFM. Semipermeable hollow fiber membranes in hepatocyte bioreactors: A prerequlsite for a successful bioartificial liver? Artif Organs 1997; 21: 1177-81.
8. Dixit V, Gitnick G. Artificial liver support: State of the art. Scand J Gastroenterol 1996; 31: 101-14.
9. Fremond B, Joly A, Desille M, Desjardins JF, Campion JP, Clement B. Cell-based therapy of acute liver failure: The extracorporeal bioartificial liver. Cell Biol Toxicol 1996; 12: 325-9.
10. Uchino J, Tsuburaya T, Kumagai F, et al. A hybrid bioartificial liver composed of multiplate hepatocyte monolayers. ASAIO Trans 1988; 34: 972-7.
11. Bader A, Knop E, Fruhauf N, et al. Reconstruction of liver tissue in vitro: Geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liver. Int J Artif Organs 1995; 19: 941-50.
12. Sussman NL, Gislason GT, Conlin CA, Kerry JH. The hepatic extracorporeal liver assist device: Initial clinical experience. Int J Artif Organs 1994; 18: 390-6.
13. Watanabe F, Mullon CJ-P, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial. Ann Surg 1997; 5: 484-94.
14. Kardassis D, Busse B, Kraemer MR, Smith MD, Neuhaus P, Gerlach JC. Hemodynamic effects if therapy with a hybrid liver support system (Abstract). ASAIO J 1999; 45: 203.
15. Matsushita T, Ijima H, Koide N, Funatsu K. High albumin production by multicellular spheroids of adult rat hepatocytes formed in the pores of polyurethane foam. Appl Microbiol Biotechnol 1991; 36: 324-6.
16. Ijima H, Nakazawa K, Mizumoto H, Matsushita T, Funatsu K. Formation of a spherical multicellular aggregate (spheroid) of animal cells in the pores of polyurethane foam as a cell culture substratum and its application to a hybrid artificial liver. J Biomat Sci 1998; 9: 765-78.
17. Fukuda J, Sakiyama R, Nakazawa K, et al. Mass preparation of primary porcine hepatocytes and the design of a hybrid artificial liver module using spheroid culture for a clinical trial. Int J Artif Organs 2001; 24: 799-806.
18. Gion T, Shimada M, Shirabe K, et al. Evaluation of hybrid artificial liver using a polyurethane foam packed-bed culture system in dogs. J Surg Res 1999; 82: 131-6.
19. Ijima H, Nakazawa K, Koyama S, et al. Conditions required for a hybrid artificial liver support system using a PUF/hepatocyte-spheroid packed-bed module and it's use in dogs with liver failure. Int J Artif Organs 2000; 23: 446-53.
20. Nakazawa K, Ijima H, Fukuda J, et al. Development of a hybrid artificial liver using polyurethane foam/hepatocyte spheroid culture in a preclinical pig experiment. Int J Artif Organs 2002; 25: 51-60.
21. Suh KS, Lilja H, Kamohara Y, et al. Bioartificial liver treatment in rats with fulminant hepatic failure: Effect on DNA-binding activity of liver-enriched and growth-associated transcription factor. J. Surg Res 1999; 85: 243-50.
22. Chervas-Mons V, Colas A, Rivera JA, Praados E. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: A controlled study in pigs. Transplantation 2000; 69: 337-44.
23. Ijima H, Noguchi A, Katsuno T, et al. Evaluating the performance of a hybrid artificial liver support system with a recoverable hepatic failure rat model. Ann N Y Acad Sci 2001; 944: 344-9.
24. Seglen PO. Preparation of isolated rat liver cells. In: Prescott, eds. Methods Cell Biology. vol. 13 D.M. New York: Academic Press, 1976. pp. 29-83.
25. Higgins GM, Anderson RM. Restoration of the liver of the white rat following partial surgical removal. AMA Arch Pathol 1931; 12: 186.
26. Matsubara S. Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure. Artif Organs 1994; 18: 363-6.
27. Denis J, Opolon P, Nusionovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by hemodialysis with high permeability membrane. Gut 1978; 19: 787-93.
28. Hughes RD, Williams R. Use of sorbent columns and hemofiltration in fulminant hepatic failure. Blood Purif 1993; 11: 163-9.
29. Hoofnagle JH, Carithers Jr RL, Shapiro C, Ascher N. Fulminant hepatic failure: Summary of a workshop. Hepatology 1995; 21: 240-50.
30. Kamohara Y, Fujioka H, Eguchi S, Kawashita Y, Furui J, Kanematsu T. Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure. Artif Organs 2000; 24: 265-70.
31. Eguchi S, Sugiyama N, Kawazoe Y, et al. Total blood exchange suppresses the early stage of liver regeneration following partial hepatectomy in rats. Artif Organs 1998; 22: 847-53.